Co-Diagnostics (CODX) Set to Announce Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) will be releasing its earnings data after the market closes on Thursday, November 7th. Analysts expect Co-Diagnostics to post earnings of ($0.33) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Co-Diagnostics (NASDAQ:CODX) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.34) by $0.09. The business had revenue of $2.66 million for the quarter, compared to the consensus estimate of $0.40 million. Co-Diagnostics had a negative net margin of 411.18% and a negative return on equity of 44.69%. On average, analysts expect Co-Diagnostics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Co-Diagnostics Stock Performance

CODX stock opened at $1.22 on Thursday. The company has a 50 day moving average price of $1.30 and a two-hundred day moving average price of $1.25. The stock has a market capitalization of $38.93 million, a P/E ratio of -0.92 and a beta of -0.87. Co-Diagnostics has a one year low of $1.00 and a one year high of $2.23.

Analysts Set New Price Targets

Separately, HC Wainwright dropped their target price on Co-Diagnostics from $2.00 to $1.50 and set a “neutral” rating for the company in a research note on Monday, August 12th.

Co-Diagnostics Company Profile

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.